vimarsana.com

Latest Breaking News On - Patrick dolezal - Page 1 : vimarsana.com

LifeSci Capital Sticks to Their Buy Rating for Avadel Pharmaceuticals (AVDL)

In a report released today, Patrick Dolezal from LifeSci Capital maintained a Buy rating on Avadel Pharmaceuticals (AVDL – Research Report.

Patrick dolezalAvadel pharmaceuticals plcVectivbio holdingAvadel pharmaceuticalsLifesci capitalResearch reportCymabay therapeuticsStrong buyPharmaceuticals plc

CymaBay Therapeutics, Inc (NASDAQ:CBAY) Q1 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen, and welcome to CymaBay’s First Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.

Sujal shahKristen kluskaHarish shantharamJay olsonAndy hsiehPatrick dolezalLewis stuartCharles mcwherterRaymond jamesYasmeen rahimiPaul quinlanEd arceMayank mamtaniPiper sandlerSteve seedhouseChuck mcwherter

LifeSci Capital Remains a Buy on Avadel Pharmaceuticals (AVDL)

In a report released yesterday, Patrick Dolezal from LifeSci Capital reiterated a Buy rating on Avadel Pharmaceuticals (AVDL – Research Re.

Patrick dolezalAvadel pharmaceuticals plcAvadel pharmaceuticalsVectivbio holdingLifesci capitalResearch reportVerve therapeuticsStrong buyAvadel pharmaceuticalPharmaceuticals plc

CymaBay Therapeutics, Inc (CBAY) Q3 2022 Earnings Call Transcript

CymaBay Therapeutics, Inc. (NASDAQ:NASDAQ:CBAY) Q3 2022 Earnings Conference Call November 14, 2022 16:30 ET Company Participants Paul Quinlan - General Counsel Sujal Shah - Chief Executive.

United statesUnited kingdomEd arceRaymond jamesDan menoldMayank mamtaniSteven seedhouseChris bowlusPaul quinlanLewis stuartTom smithKristen kluskaJay olsonDennis kimPiper sandlerSujal shah

Oyster Point Pharma, Inc (OYST) Q2 2022 Earnings Call Transcript

OYST earnings call for the period ending June 30, 2022.

United statesJi xingDaniil gataulinJoe catanzaroMike campbellPiper sandlerDan lochnerPatrick dolezal lifesciPatrick dolezalDaniil gataulin chardanJoe catanzaro piper sandlerOyster point pharma incCompany analystOyster point pharmaParty ahmedJeffrey nau

vimarsana © 2020. All Rights Reserved.